Key points from article :
New pill may inhibit or reduce some of the degenerative affects of aging and injury.
Special Operations Command (SOCOM) expects to move into clinical trials with it next year.
It is a part of a broader Pentagon push for “improved human performance.”
If it is successful, then the pill has the potential to truly delay aging, truly prevent onset of injury.
Navy Cmdr. Tim Hawkins, a SOCOM spokesperson, says "We have completed pre-clinical safety and dosing studies..."
SOCOM is using OTA funds to partner with MetroBiotech in the pill’s development.
Which is called a human performance small molecule.
They are working with leading industry partners and clinical research institutions to develop a nutraceutical.
A pill that is suitable for a variety of uses by both civilians and military members.
Preclinical evidence suggests disease- and age-related functional decline can be mitigated by boosting NAD+.
Maintaining optimal NAD+ levels may allow humans to lead longer and healthier lives.
